Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,720 | -3,645 | 11,647 | -84,900 | -57,750 |
| Depreciation Amortization | 9,800 | 6,531 | 3,260 | 14,140 | 10,630 |
| Income taxes - deferred | -745 | 3,442 | 5,864 | -2,113 | N/A |
| Accounts receivable | -1,363 | 467 | 1,376 | 3,249 | N/A |
| Accounts payable and accrued liabilities | 2,387 | 2,194 | 2,295 | 7,219 | N/A |
| Other Working Capital | -8,561 | -3,242 | 9,183 | N/A | 9,480 |
| Other Operating Activity | 88,097 | 33,554 | -8,350 | 51,795 | 33,340 |
| Operating Cash Flow | $57,895 | $39,301 | $25,275 | $-10,610 | $-4,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,051 | -9,897 | -23,195 | -54,597 | N/A |
| PPE Investments | -1,077 | -659 | -234 | -1,720 | -57,060 |
| Other Investing Activity | 0 | 0 | 0 | 13,237 | 0 |
| Investing Cash Flow | $-23,128 | $-10,556 | $-23,429 | $-43,080 | $-57,060 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,743 | -6,406 | N/A | -34,908 | N/A |
| Common Stock Issued | 6,990 | 1,652 | 246 | 132,260 | N/A |
| Other Financing Activity | -15,497 | -6,118 | -325 | -1,362 | 83,060 |
| Financing Cash Flow | $-16,250 | $-10,872 | $-79 | $95,990 | $83,060 |
| Exchange Rate Effect | -2,236 | -2,397 | -2,992 | -9,170 | -4,330 |
| Beginning Cash Position | 39,760 | 39,760 | 39,760 | 6,630 | 6,630 |
| End Cash Position | 56,041 | 55,236 | 38,535 | 39,760 | 24,000 |
| Net Cash Flow | $16,281 | $15,476 | $-1,225 | $33,120 | $17,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57,895 | 39,301 | 25,275 | -10,610 | -4,300 |
| Capital Expenditure | -1,077 | -659 | -234 | -1,728 | N/A |
| Free Cash Flow | 56,818 | 38,642 | 25,041 | -12,338 | -4,300 |